230 related articles for article (PubMed ID: 22857536)
21. Preparation and activity of some novel organo-metallic complexes against Helicobacter pylori.
Nagarajan R; Mehta SI; Naik SR; Fabry W
Arzneimittelforschung; 1999 Nov; 49(11):951-4. PubMed ID: 10604049
[TBL] [Abstract][Full Text] [Related]
22. Chemistry and Some Biological Potential of Bismuth and Antimony Dithiocarbamate Complexes.
Adeyemi JO; Onwudiwe DC
Molecules; 2020 Jan; 25(2):. PubMed ID: 31940910
[TBL] [Abstract][Full Text] [Related]
23. Bismuth(III) complexes derived from non-steroidal anti-inflammatory drugs and their activity against Helicobacter pylori.
Andrews PC; Ferrero RL; Junk PC; Kumar I; Luu Q; Nguyen K; Taylor JW
Dalton Trans; 2010 Mar; 39(11):2861-8. PubMed ID: 20200713
[TBL] [Abstract][Full Text] [Related]
24. The antimicrobial activity of inert oligonuclear polypyridylruthenium(II) complexes against pathogenic bacteria, including MRSA.
Li F; Mulyana Y; Feterl M; Warner JM; Collins JG; Keene FR
Dalton Trans; 2011 May; 40(18):5032-8. PubMed ID: 21442118
[TBL] [Abstract][Full Text] [Related]
25. Microwave-induced Bismuth Salts-mediated Synthesis of Molecules of Medicinal Interests.
Bandyopadhyay D; Chavez A; Banik BK
Curr Med Chem; 2017; 24(41):4677-4713. PubMed ID: 28322155
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, crystal structures, in vitro biological evaluation of zinc(II) and bismuth(III) complexes of 2-acetylpyrazine N(4)-phenylthiosemicarbazone.
Li MX; Zhang LZ; Yang M; Niu JY; Zhou J
Bioorg Med Chem Lett; 2012 Apr; 22(7):2418-23. PubMed ID: 22401862
[TBL] [Abstract][Full Text] [Related]
27. The C terminus of HspA--a potential target for native Ni(II) and Bi(III) anti-ulcer drugs.
Rowinska-Zyrek M; Witkowska D; Valensin D; Kamysz W; Kozlowski H
Dalton Trans; 2010 Jul; 39(25):5814-26. PubMed ID: 20502777
[TBL] [Abstract][Full Text] [Related]
28. Functional disruption of peroxiredoxin by bismuth antiulcer drugs attenuates Helicobacter pylori survival.
Chang YY; Cheng T; Yang X; Jin L; Sun H; Li H
J Biol Inorg Chem; 2017 Jul; 22(5):673-683. PubMed ID: 28361362
[TBL] [Abstract][Full Text] [Related]
29. Structural and solution studies of phenylbismuth(III) sulfonate complexes and their activity against Helicobacter pylori.
Andrews PC; Busse M; Deacon GB; Ferrero RL; Junk PC; Huynh KK; Kumar I; Maclellan JG
Dalton Trans; 2010 Oct; 39(40):9633-41. PubMed ID: 20830402
[TBL] [Abstract][Full Text] [Related]
30. Chemistry and biological activity of platinum amidine complexes.
Michelin RA; Sgarbossa P; Sbovata SM; Gandin V; Marzano C; Bertani R
ChemMedChem; 2011 Jul; 6(7):1172-83. PubMed ID: 21630470
[TBL] [Abstract][Full Text] [Related]
31. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
32. Screening of antimicrobial activity of Cistus ladanifer and Arbutus unedo extracts.
Ferreira S; Santos J; Duarte A; Duarte AP; Queiroz JA; Domingues FC
Nat Prod Res; 2012; 26(16):1558-60. PubMed ID: 22077559
[TBL] [Abstract][Full Text] [Related]
33. Bismuth(III) complexes with 2-acetylpyridine- and 2-benzoylpyridine-derived hydrazones: Antimicrobial and cytotoxic activities and effects on the clonogenic survival of human solid tumor cells.
Ferreira IP; Piló EDL; Recio-Despaigne AA; Da Silva JG; Ramos JP; Marques LB; Prazeres PHDM; Takahashi JA; Souza-Fagundes EM; Rocha W; Beraldo H
Bioorg Med Chem; 2016 Jul; 24(13):2988-2998. PubMed ID: 27209169
[TBL] [Abstract][Full Text] [Related]
34. Perspective: the potential of pyrazole-based compounds in medicine.
Keter FK; Darkwa J
Biometals; 2012 Feb; 25(1):9-21. PubMed ID: 22002344
[TBL] [Abstract][Full Text] [Related]
35. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
36. Histochemical tracing of bismuth in Helicobacter pylori after in vitro exposure to bismuth citrate.
Stoltenberg M; Martiny M; Sørensen K; Rungby J; Krogfelt KA
Scand J Gastroenterol; 2001 Feb; 36(2):144-8. PubMed ID: 11252405
[TBL] [Abstract][Full Text] [Related]
37. Applications of asymmetric organocatalysis in medicinal chemistry.
Alemán J; Cabrera S
Chem Soc Rev; 2013 Jan; 42(2):774-93. PubMed ID: 23154582
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, antimicrobial and antiproliferative activity of novel silver(I) tris(pyrazolyl)methanesulfonate and 1,3,5-triaza-7-phosphadamantane complexes.
Pettinari C; Marchetti F; Lupidi G; Quassinti L; Bramucci M; Petrelli D; Vitali LA; da Silva MF; Martins LM; Smoleński P; Pombeiro AJ
Inorg Chem; 2011 Nov; 50(21):11173-83. PubMed ID: 21999582
[TBL] [Abstract][Full Text] [Related]
39. Pyrazole containing natural products: synthetic preview and biological significance.
Kumar V; Kaur K; Gupta GK; Sharma AK
Eur J Med Chem; 2013 Nov; 69():735-53. PubMed ID: 24099993
[TBL] [Abstract][Full Text] [Related]
40. Chemistry and applications of organotin(IV) complexes of Schiff bases.
Nath M; Saini PK
Dalton Trans; 2011 Jul; 40(27):7077-121. PubMed ID: 21494719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
